Activity of NEO2734, a novel dual inhibitor of both BET and CBP-P300, in SPOP-mutated prostate cancer.

CBP/P300 inhibitor - EPIGeNE, Epigenetix

JQ-1 - Roche

https://meetinglibrary.asco.org/record/169916

Yuqian Yan; Dejie Wang; Jian Ma; Xiaodong Pang; Dong Lin; Francis Giles; Yuzhuo Wang; Haojie Huang

Feb 12, 2019